Sarcoidosis of lung with sarcoidosis of lymph nodes
ICD-10 D86.2 is a billable code used to indicate a diagnosis of sarcoidosis of lung with sarcoidosis of lymph nodes.
Sarcoidosis is a systemic granulomatous disease characterized by the formation of non-caseating granulomas in various organs, most commonly the lungs and lymph nodes. In the case of D86.2, the condition specifically involves sarcoidosis affecting both the lung parenchyma and the lymph nodes, which may present with respiratory symptoms such as cough, dyspnea, and chest pain, alongside systemic symptoms like fatigue and weight loss. The diagnosis is often confirmed through imaging studies, such as chest X-rays or CT scans, which reveal bilateral hilar lymphadenopathy and pulmonary infiltrates. Bronchoscopy with biopsy may also be performed to obtain tissue samples for histological examination. The management of sarcoidosis may include observation, corticosteroids, or immunosuppressive therapy, depending on the severity of the disease and the presence of symptoms. The interplay between lung involvement and lymphadenopathy can complicate the clinical picture, necessitating careful monitoring and treatment adjustments.
Detailed clinical notes on respiratory symptoms, imaging results, and treatment plans.
Patients presenting with cough, dyspnea, and abnormal chest imaging.
Ensure clear documentation of lung function tests and response to therapy.
Comprehensive assessment of systemic symptoms and potential extrapulmonary manifestations.
Patients with joint pain or skin lesions alongside respiratory symptoms.
Document any autoimmune conditions that may coexist with sarcoidosis.
Used for obtaining biopsy samples in suspected sarcoidosis cases.
Document indication for bronchoscopy and findings.
Pulmonologists should ensure clear documentation of the procedure and its necessity.
Common symptoms include persistent cough, shortness of breath, chest pain, fatigue, and systemic symptoms like fever and weight loss.
Diagnosis is typically made through a combination of clinical evaluation, imaging studies, and biopsy to confirm the presence of non-caseating granulomas.
